Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Prepaid Assets (2016 - 2025)

Enanta Pharmaceuticals (ENTA) has disclosed Prepaid Assets for 14 consecutive years, with $4.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Prepaid Assets fell 59.36% year-over-year to $4.3 million, compared with a TTM value of $4.3 million through Dec 2025, down 59.36%, and an annual FY2025 reading of $8.6 million, down 30.8% over the prior year.
  • Prepaid Assets was $4.3 million for Q4 2025 at Enanta Pharmaceuticals, down from $8.6 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $32.1 million in Q1 2021 and bottomed at $4.3 million in Q4 2025.
  • Average Prepaid Assets over 5 years is $13.3 million, with a median of $12.8 million recorded in 2023.
  • The sharpest move saw Prepaid Assets skyrocketed 62.04% in 2021, then crashed 59.36% in 2025.
  • Year by year, Prepaid Assets stood at $11.5 million in 2021, then surged by 55.97% to $17.9 million in 2022, then fell by 26.2% to $13.2 million in 2023, then fell by 19.34% to $10.7 million in 2024, then plummeted by 59.36% to $4.3 million in 2025.
  • Business Quant data shows Prepaid Assets for ENTA at $4.3 million in Q4 2025, $8.6 million in Q3 2025, and $10.2 million in Q2 2025.